{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T23:53:02Z","timestamp":1781653982253,"version":"3.54.5"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:00:00Z","timestamp":1771459200000},"content-version":"vor","delay-in-days":16,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Innovative Research Program for Graduates of Basic Medical College, Hubei University of Medicine","award":["JC2024007"],"award-info":[{"award-number":["JC2024007"]}]},{"DOI":"10.13039\/501100003819","name":"Natural Science Foundation of Hubei Province","doi-asserted-by":"crossref","award":["2025AFD054"],"award-info":[{"award-number":["2025AFD054"]}],"id":[{"id":"10.13039\/501100003819","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Shiyan Municipal Science and Technology Bureau Project","award":["25Y132"],"award-info":[{"award-number":["25Y132"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The immune microenvironment and prognosis of bladder cancer (BLCA) remain ongoing challenges in its treatment. This study aimed to establish predictive prognostic indicators and investigate the immune microenvironment to enhance clinical treatment strategies. A single-cell transcriptional atlas was constructed using single-cell RNA-seq data from patients with bladder cancer, focusing on fibroblast-related gene expression, intercellular communication, metabolic pathways inferred by single-cell flux estimation analysis, and transcription factor networks. Fibroblast-associated prognostic gene signatures were validated using data from The Cancer Genome Atlas, and a prognostic model was developed to stratify patients with bladder cancer into high- and low-risk groups. Analysis of three para-carcinoma single-cell samples revealed the presence of 3,603 fibroblasts and 500 fibroblast-associated marker genes. Notably, key fibroblast-specific transcription factors, including MAF, TWIST1, and TCF21, were identified through SCENIC analysis. The incorporation of comprehensive RNA sequencing data enabled the discovery of prognostic markers associated with fibroblasts. Using this classification model, patient survival could be stratified into high- and low-risk categories based on the model. The results of our study highlight the prognostic genetic signatures associated with the fibroblast component of the immune microenvironment in BLCA, offering preliminary insights into prognostic assessment and potential therapeutic implications.<\/jats:p>","DOI":"10.1038\/s41598-026-38219-x","type":"journal-article","created":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T13:26:52Z","timestamp":1770125212000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Single-cell transcriptomics identifies fibroblast associated immune heterogeneity and prognostic signatures in bladder cancer"],"prefix":"10.1038","volume":"16","author":[{"given":"Xiaojuan","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zilong","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Xi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,3]]},"reference":[{"issue":"19","key":"38219_CR1","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1001\/jama.2020.17598","volume":"324","author":"AT Lenis","year":"2020","unstructured":"Lenis, A. T., Lec, P. M., Chamie, K. & Mshs, M. D. Bladder cancer: A review. Jama 324(19), 1980\u20131991. https:\/\/doi.org\/10.1001\/jama.2020.17598 (2020).","journal-title":"Jama"},{"issue":"3","key":"38219_CR2","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71(3), 209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660 (2021).","journal-title":"CA Cancer J. Clin."},{"issue":"Supp. 1","key":"38219_CR3","doi-asserted-by":"publisher","first-page":"S71","DOI":"10.5152\/tud.2020.20337","volume":"47","author":"NP Omorphos","year":"2021","unstructured":"Omorphos, N. P., Piedad, J. C. P. & Vasdev, N. Guideline of guidelines: Muscle-invasive bladder cancer. Turk. J. Urol. 47(Supp. 1), S71\u2013s8. https:\/\/doi.org\/10.5152\/tud.2020.20337 (2021).","journal-title":"Turk. J. Urol."},{"issue":"3","key":"38219_CR4","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.annonc.2021.11.012","volume":"33","author":"T Powles","year":"2022","unstructured":"Powles, T. et al. Bladder cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up. Ann. Oncol. 33(3), 244\u2013258. https:\/\/doi.org\/10.1016\/j.annonc.2021.11.012 (2022).","journal-title":"Ann. Oncol."},{"issue":"6","key":"38219_CR5","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1158\/2326-6066.CIR-18-0758","volume":"7","author":"C Pfannstiel","year":"2019","unstructured":"Pfannstiel, C. et al. The tumor immune microenvironment drives a prognostic relevance that correlates with bladder cancer subtypes. Cancer Immunol. Res. 7(6), 923\u2013938. https:\/\/doi.org\/10.1158\/2326-6066.CIR-18-0758 (2019).","journal-title":"Cancer Immunol. Res."},{"key":"38219_CR6","doi-asserted-by":"publisher","first-page":"1105026","DOI":"10.3389\/fonc.2022.1105026","volume":"12","author":"Z Chen","year":"2022","unstructured":"Chen, Z., Chen, D., Song, Z., Lv, Y. & Qi, D. Mapping the tumor microenvironment in bladder cancer and exploring the prognostic genes by single-cell RNA sequencing. Front. Oncol. 12, 1105026. https:\/\/doi.org\/10.3389\/fonc.2022.1105026 (2022).","journal-title":"Front. Oncol."},{"key":"38219_CR7","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.omto.2021.02.001","volume":"20","author":"J Meng","year":"2021","unstructured":"Meng, J. et al. Tumor immune microenvironment-based classifications of bladder cancer for enhancing the response rate of immunotherapy. Mol. Ther. Oncolytics. 20, 410\u2013421. https:\/\/doi.org\/10.1016\/j.omto.2021.02.001 (2021).","journal-title":"Mol. Ther. Oncolytics"},{"key":"38219_CR8","doi-asserted-by":"publisher","unstructured":"Zhang, P. et al. Mitochondrial Pathway Signature (MitoPS) predicts immunotherapy response and reveals NDUFB10 as a key immune regulator in lung adenocarcinoma. J. Immunother Cancer.. 13(7). https:\/\/doi.org\/10.1136\/jitc-2025-012069 (2025).","DOI":"10.1136\/jitc-2025-012069"},{"issue":"1","key":"38219_CR9","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1186\/s12943-024-02183-9","volume":"23","author":"H Wang","year":"2024","unstructured":"Wang, H. et al. Crosstalk of pyroptosis and cytokine in the tumor microenvironment: from mechanisms to clinical implication. Mol. Cancer. 23(1), 268. https:\/\/doi.org\/10.1186\/s12943-024-02183-9 (2024).","journal-title":"Mol. Cancer"},{"issue":"2","key":"38219_CR10","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/s41573-018-0004-1","volume":"18","author":"X Chen","year":"2019","unstructured":"Chen, X. & Song, E. Turning foes to friends: targeting cancer-associated fibroblasts. Nat. Rev. Drug Discov. 18(2), 99\u2013115. https:\/\/doi.org\/10.1038\/s41573-018-0004-1 (2019).","journal-title":"Nat. Rev. Drug Discov"},{"issue":"1","key":"38219_CR11","doi-asserted-by":"publisher","first-page":"2438291","DOI":"10.1080\/2162402x.2024.2438291","volume":"14","author":"CG Ca\u00f1izo","year":"2025","unstructured":"Ca\u00f1izo, C. G. et al. Characterisation of the tumour microenvironment and PD-L1 granularity reveals the prognostic value of cancer-associated myofibroblasts in non-invasive bladder cancer. Oncoimmunology 14(1), 2438291. https:\/\/doi.org\/10.1080\/2162402x.2024.2438291 (2025).","journal-title":"Oncoimmunology"},{"issue":"4","key":"38219_CR12","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.euo.2023.02.011","volume":"6","author":"B Caramelo","year":"2023","unstructured":"Caramelo, B., Zagorac, S., Corral, S., Marqu\u00e9s, M. & Real, F. X. Cancer-associated fibroblasts in bladder cancer: Origin, biology, and therapeutic opportunities. Eur. Urol. Oncol. 6(4), 366\u2013375. https:\/\/doi.org\/10.1016\/j.euo.2023.02.011 (2023).","journal-title":"Eur. Urol. Oncol."},{"key":"38219_CR13","doi-asserted-by":"publisher","first-page":"1002304","DOI":"10.37349\/etat.2025.1002304","volume":"6","author":"A Di Spirito","year":"2025","unstructured":"Di Spirito, A., Balkhi, S., Vivona, V. & Mortara, L. Key immune cells and their crosstalk in the tumor microenvironment of bladder cancer: insights for innovative therapies. Explor. Target. Antitumor Ther. 6, 1002304. https:\/\/doi.org\/10.37349\/etat.2025.1002304 (2025).","journal-title":"Explor. Target. Antitumor Ther."},{"key":"38219_CR14","doi-asserted-by":"crossref","unstructured":"Ghahremanifard, P., Chanda, A., Bonni, S. & Bose, P. TGF-\u03b2 mediated immune evasion in cancer\u2014spotlight on cancer-associated fibroblasts. 12(12), 3650. (2020).","DOI":"10.3390\/cancers12123650"},{"issue":"1","key":"38219_CR15","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s00262-019-02443-4","volume":"69","author":"PL Crispen","year":"2020","unstructured":"Crispen, P. L. & Kusmartsev, S. Mechanisms of immune evasion in bladder cancer. Cancer Immunol. Immunother. 69(1), 3\u201314. https:\/\/doi.org\/10.1007\/s00262-019-02443-4 (2020).","journal-title":"Cancer Immunol. Immunother"},{"key":"38219_CR16","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1146\/annurev-immunol-110519-071134","volume":"39","author":"X Ren","year":"2021","unstructured":"Ren, X. et al. Insights gained from single-cell analysis of immune cells in the tumor microenvironment. Annu. Rev. Immunol. 39, 583\u2013609. https:\/\/doi.org\/10.1146\/annurev-immunol-110519-071134 (2021).","journal-title":"Annu. Rev. Immunol."},{"issue":"1","key":"38219_CR17","doi-asserted-by":"publisher","first-page":"6619","DOI":"10.1038\/s41467-022-34395-2","volume":"13","author":"H Luo","year":"2022","unstructured":"Luo, H. et al. Pan-cancer single-cell analysis reveals the heterogeneity and plasticity of cancer-associated fibroblasts in the tumor microenvironment. Nat. Commun. 13(1), 6619. https:\/\/doi.org\/10.1038\/s41467-022-34395-2 (2022).","journal-title":"Nat. Commun."},{"issue":"1","key":"38219_CR18","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s12885-022-10332-w","volume":"23","author":"Z Zhou","year":"2023","unstructured":"Zhou, Z. et al. Integrated single-cell and bulk RNA sequencing analysis identifies a cancer-associated fibroblast-related gene signature for predicting survival and therapy in gastric cancer. BMC Cancer. 23(1), 108. https:\/\/doi.org\/10.1186\/s12885-022-10332-w (2023).","journal-title":"BMC Cancer"},{"issue":"2","key":"38219_CR19","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1158\/2159-8290.Cd-19-0644","volume":"10","author":"CX Dominguez","year":"2020","unstructured":"Dominguez, C. X. et al. Single-cell RNA sequencing reveals stromal evolution into LRRC15(+) myofibroblasts as a determinant of patient response to cancer immunotherapy. Cancer Discov. 10(2), 232\u2013253. https:\/\/doi.org\/10.1158\/2159-8290.Cd-19-0644 (2020).","journal-title":"Cancer Discov"},{"key":"38219_CR20","doi-asserted-by":"publisher","first-page":"1174252","DOI":"10.3389\/fonc.2023.1174252","volume":"13","author":"M Zhang","year":"2023","unstructured":"Zhang, M. et al. Development and validation of cancer-associated fibroblasts-related gene landscape in prognosis and immune microenvironment of bladder cancer. Front. Oncol. 13, 1174252. https:\/\/doi.org\/10.3389\/fonc.2023.1174252 (2023).","journal-title":"Front. Oncol."},{"key":"38219_CR21","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/1755-8794-3-21","volume":"3","author":"A Gribov","year":"2010","unstructured":"Gribov, A. et al. SEURAT: visual analytics for the integrated analysis of microarray data. BMC Med. Genomics. 3, 21. https:\/\/doi.org\/10.1186\/1755-8794-3-21 (2010).","journal-title":"BMC Med. Genomics"},{"key":"38219_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.4314","author":"E Becht","year":"2018","unstructured":"Becht, E. et al. Dimensionality reduction for visualizing single-cell data using UMAP. Nat. Biotechnol. https:\/\/doi.org\/10.1038\/nbt.4314 (2018).","journal-title":"Nat. Biotechnol."},{"issue":"D1","key":"38219_CR23","doi-asserted-by":"publisher","first-page":"D721","DOI":"10.1093\/nar\/gky900","volume":"47","author":"X Zhang","year":"2019","unstructured":"Zhang, X. et al. CellMarker: a manually curated resource of cell markers in human and mouse. Nucleic Acids Res. 47(D1), D721\u2013d8. https:\/\/doi.org\/10.1093\/nar\/gky900 (2019).","journal-title":"Nucleic Acids Res."},{"key":"38219_CR24","doi-asserted-by":"publisher","first-page":"5978","DOI":"10.1016\/j.csbj.2022.10.028","volume":"20","author":"H Lu","year":"2022","unstructured":"Lu, H. et al. CommPath: an R package for inference and analysis of pathway-mediated cell-cell communication chain from single-cell transcriptomics. Comput. Struct. Biotechnol. J. 20, 5978\u20135983. https:\/\/doi.org\/10.1016\/j.csbj.2022.10.028 (2022).","journal-title":"Comput. Struct. Biotechnol. J."},{"issue":"10","key":"38219_CR25","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1101\/gr.271205.120","volume":"31","author":"N Alghamdi","year":"2021","unstructured":"Alghamdi, N. et al. A graph neural network model to estimate cell-wise metabolic flux using single-cell RNA-seq data. Genome Res. 31(10), 1867\u20131884. https:\/\/doi.org\/10.1101\/gr.271205.120 (2021).","journal-title":"Genome Res."},{"issue":"1","key":"38219_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v033.i01","volume":"33","author":"J Friedman","year":"2010","unstructured":"Friedman, J., Hastie, T. & Tibshirani, R. Regularization paths for generalized linear models via coordinate descent. J. Stat. Softw. 33(1), 1\u201322 (2010).","journal-title":"J. Stat. Softw."},{"issue":"7","key":"38219_CR27","doi-asserted-by":"publisher","first-page":"e1338","DOI":"10.1002\/ctm2.1338","volume":"13","author":"ZD Shi","year":"2023","unstructured":"Shi, Z. D. et al. Integrated single-cell and spatial transcriptomic profiling reveals higher intratumour heterogeneity and epithelial-fibroblast interactions in recurrent bladder cancer. Clin. Transl Med. 13(7), e1338. https:\/\/doi.org\/10.1002\/ctm2.1338 (2023).","journal-title":"Clin. Transl Med."},{"key":"38219_CR28","doi-asserted-by":"publisher","unstructured":"Joshi, R. S. et al. The role of Cancer-Associated fibroblasts in tumor progression. Cancers. 13(6). https:\/\/doi.org\/10.3390\/cancers13061399 (2021).","DOI":"10.3390\/cancers13061399"},{"key":"38219_CR29","doi-asserted-by":"publisher","unstructured":"Greco, L. et al. Epithelial to mesenchymal transition: A challenging playground for translational research. Current models and focus on TWIST1 relevance and gastrointestinal cancers. Int. J. Mol. Sci.. 22(21). https:\/\/doi.org\/10.3390\/ijms222111469 (2021).","DOI":"10.3390\/ijms222111469"},{"issue":"1","key":"38219_CR30","doi-asserted-by":"publisher","first-page":"5077","DOI":"10.1038\/s41467-020-18916-5","volume":"11","author":"Z Chen","year":"2020","unstructured":"Chen, Z. et al. Single-cell RNA sequencing highlights the role of inflammatory cancer-associated fibroblasts in bladder urothelial carcinoma. Nat. Commun. 11(1), 5077. https:\/\/doi.org\/10.1038\/s41467-020-18916-5 (2020).","journal-title":"Nat. Commun."},{"issue":"3","key":"38219_CR31","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/s41568-019-0238-1","volume":"20","author":"E Sahai","year":"2020","unstructured":"Sahai, E. et al. A framework for advancing our understanding of cancer-associated fibroblasts. Nat. Rev. Cancer. 20(3), 174\u2013186. https:\/\/doi.org\/10.1038\/s41568-019-0238-1 (2020).","journal-title":"Nat. Rev. Cancer"},{"issue":"12","key":"38219_CR32","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1038\/s41571-021-00546-5","volume":"18","author":"Y Chen","year":"2021","unstructured":"Chen, Y., McAndrews, K. M. & Kalluri, R. Clinical and therapeutic relevance of cancer-associated fibroblasts. Nat. Rev. Clin. Oncol. 18(12), 792\u2013804. https:\/\/doi.org\/10.1038\/s41571-021-00546-5 (2021).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"38219_CR33","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.matbio.2015.06.003","volume":"49","author":"A Naba","year":"2016","unstructured":"Naba, A. et al. The extracellular matrix: tools and insights for the omics era. Matrix Biol. 49, 10\u201324. https:\/\/doi.org\/10.1016\/j.matbio.2015.06.003 (2016).","journal-title":"Matrix Biol."},{"key":"38219_CR34","doi-asserted-by":"publisher","unstructured":"Costanza, B., Umelo, I. A., Bellier, J., Castronovo, V. & Turtoi, A. Stromal modulators of TGF-\u03b2 in cancer. J. Clin. Med. 6(1). https:\/\/doi.org\/10.3390\/jcm6010007 (2017).","DOI":"10.3390\/jcm6010007"},{"issue":"4","key":"38219_CR35","doi-asserted-by":"publisher","first-page":"e0214606","DOI":"10.1371\/journal.pone.0214606","volume":"14","author":"C Yin","year":"2019","unstructured":"Yin, C., Liu, W. H., Liu, Y., Wang, L. & Xiao, Y. PID1 alters the antilipolytic action of insulin and increases lipolysis via inhibition of AKT\/PKA pathway activation. PLoS One. 14(4), e0214606. https:\/\/doi.org\/10.1371\/journal.pone.0214606 (2019).","journal-title":"PLoS One"},{"issue":"1","key":"38219_CR36","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/s41420-023-01405-1","volume":"9","author":"J Yang","year":"2023","unstructured":"Yang, J. et al. Dual role of PID1 in regulating apoptosis induced by distinct anticancer-agents through AKT\/Raf-1-dependent pathway in hepatocellular carcinoma. Cell. Death Discov. 9(1), 139. https:\/\/doi.org\/10.1038\/s41420-023-01405-1 (2023).","journal-title":"Cell. Death Discov"},{"issue":"21","key":"38219_CR37","doi-asserted-by":"publisher","first-page":"6376","DOI":"10.7150\/jca.46309","volume":"11","author":"R Hong","year":"2020","unstructured":"Hong, R. et al. PRELP has prognostic value and regulates cell proliferation and migration in hepatocellular carcinoma. J. Cancer. 11(21), 6376\u20136389. https:\/\/doi.org\/10.7150\/jca.46309 (2020).","journal-title":"J. Cancer"},{"key":"38219_CR38","doi-asserted-by":"publisher","unstructured":"Hopkins, J. et al. PRELP regulates Cell-Cell adhesion and EMT and inhibits retinoblastoma progression. Cancers. 14(19). https:\/\/doi.org\/10.3390\/cancers14194926 (2022).","DOI":"10.3390\/cancers14194926"},{"issue":"3","key":"38219_CR39","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/s41568-022-00543-5","volume":"23","author":"DA Guertin","year":"2023","unstructured":"Guertin, D. A. & Wellen, K. E. Acetyl-CoA metabolism in cancer. Nat. Rev. Cancer. 23(3), 156\u2013172. https:\/\/doi.org\/10.1038\/s41568-022-00543-5 (2023).","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"38219_CR40","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1743-7075-11-10","volume":"11","author":"S Zhang","year":"2014","unstructured":"Zhang, S., Hulver, M. W., McMillan, R. P., Cline, M. A. & Gilbert, E. R. The pivotal role of pyruvate dehydrogenase kinases in metabolic flexibility. Nutr. Metab. (Lond). 11(1), 10. https:\/\/doi.org\/10.1186\/1743-7075-11-10 (2014).","journal-title":"Nutr. Metab. (Lond)"},{"issue":"1","key":"38219_CR41","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s12967-024-04848-x","volume":"22","author":"G Yang","year":"2024","unstructured":"Yang, G. et al. Metabolic heterogeneity in clear cell renal cell carcinoma revealed by single-cell RNA sequencing and spatial transcriptomics. J. Transl Med. 22(1), 210. https:\/\/doi.org\/10.1186\/s12967-024-04848-x (2024).","journal-title":"J. Transl Med."},{"key":"38219_CR42","doi-asserted-by":"publisher","first-page":"68","DOI":"10.3389\/fonc.2017.00068","volume":"7","author":"S Gupta","year":"2017","unstructured":"Gupta, S., Roy, A. & Dwarakanath, B. S. Metabolic cooperation and competition in the tumor microenvironment: implications for therapy. Front. Oncol. 7, 68. https:\/\/doi.org\/10.3389\/fonc.2017.00068 (2017).","journal-title":"Front. Oncol."},{"key":"38219_CR43","doi-asserted-by":"publisher","unstructured":"Mishra, D. & Banerjee, D. Lactate dehydrogenases as metabolic links between tumor and stroma in the tumor microenvironment. Cancers. 11(6). https:\/\/doi.org\/10.3390\/cancers11060750 (2019).","DOI":"10.3390\/cancers11060750"},{"issue":"5","key":"38219_CR44","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1158\/1078-0432.Ccr-20-3054","volume":"27","author":"JH Strickler","year":"2021","unstructured":"Strickler, J. H., Hanks, B. A. & Khasraw, M. Tumor mutational burden as a predictor of immunotherapy response: is more always better? Clin. Cancer Res. 27(5), 1236\u20131241. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-20-3054 (2021).","journal-title":"Clin. Cancer Res."},{"key":"38219_CR45","doi-asserted-by":"publisher","first-page":"1573480","DOI":"10.3389\/fgene.2025.1573480","volume":"16","author":"X Xiong","year":"2025","unstructured":"Xiong, X., Liu, W. & Yao, C. Development of an alkaliptosis-related LncRNA risk model and immunotherapy target analysis in lung adenocarcinoma. Front. Genet. 16, 1573480. https:\/\/doi.org\/10.3389\/fgene.2025.1573480 (2025).","journal-title":"Front. Genet."},{"issue":"9","key":"38219_CR46","doi-asserted-by":"publisher","first-page":"e1629258","DOI":"10.1080\/2162402x.2019.1629258","volume":"8","author":"D Cao","year":"2019","unstructured":"Cao, D., Xu, H., Xu, X., Guo, T. & Ge, W. High tumor mutation burden predicts better efficacy of immunotherapy: a pooled analysis of 103078 cancer patients. Oncoimmunology 8(9), e1629258. https:\/\/doi.org\/10.1080\/2162402x.2019.1629258 (2019).","journal-title":"Oncoimmunology"},{"issue":"2","key":"38219_CR47","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.ccell.2020.10.001","volume":"39","author":"DL Jardim","year":"2021","unstructured":"Jardim, D. L., Goodman, A., de Melo Gagliato, D. & Kurzrock, R. The challenges of tumor mutational burden as an immunotherapy biomarker. Cancer Cell. 39(2), 154\u2013173. https:\/\/doi.org\/10.1016\/j.ccell.2020.10.001 (2021).","journal-title":"Cancer Cell."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-38219-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-38219-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-38219-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T23:02:44Z","timestamp":1781650964000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-38219-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,3]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["38219"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-38219-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,3]]},"assertion":[{"value":"30 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors contributed to the article and approved the submitted version.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Consent for publication"}},{"value":"All procedures were performed in compliance with relevant laws and institutional guidelines and have been approved by the Professional Committee of Scientific Research and Academic Ethics of Shiyan People\u2019s Hospital, consent was obtained for experimentation with human subjects. The date and reference number of the ethical approval(s) obtained: May 19, 2025; SYRMYY-2025-059.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Ethics approval"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7151"}}